1. Home
  2. SNCR vs TLSA Comparison

SNCR vs TLSA Comparison

Compare SNCR & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • TLSA
  • Stock Information
  • Founded
  • SNCR 2000
  • TLSA 2013
  • Country
  • SNCR United States
  • TLSA United Kingdom
  • Employees
  • SNCR N/A
  • TLSA N/A
  • Industry
  • SNCR EDP Services
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNCR Technology
  • TLSA Health Care
  • Exchange
  • SNCR Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • SNCR 101.2M
  • TLSA 87.8M
  • IPO Year
  • SNCR 2006
  • TLSA 2000
  • Fundamental
  • Price
  • SNCR $9.82
  • TLSA $0.94
  • Analyst Decision
  • SNCR Strong Buy
  • TLSA
  • Analyst Count
  • SNCR 1
  • TLSA 0
  • Target Price
  • SNCR $13.00
  • TLSA N/A
  • AVG Volume (30 Days)
  • SNCR 145.8K
  • TLSA 640.2K
  • Earning Date
  • SNCR 05-06-2025
  • TLSA 05-09-2025
  • Dividend Yield
  • SNCR N/A
  • TLSA N/A
  • EPS Growth
  • SNCR N/A
  • TLSA N/A
  • EPS
  • SNCR 0.43
  • TLSA N/A
  • Revenue
  • SNCR $173,594,000.00
  • TLSA N/A
  • Revenue This Year
  • SNCR $5.08
  • TLSA N/A
  • Revenue Next Year
  • SNCR $2.43
  • TLSA N/A
  • P/E Ratio
  • SNCR $25.14
  • TLSA N/A
  • Revenue Growth
  • SNCR 5.72
  • TLSA N/A
  • 52 Week Low
  • SNCR $6.02
  • TLSA $0.41
  • 52 Week High
  • SNCR $15.46
  • TLSA $1.91
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 51.51
  • TLSA 40.18
  • Support Level
  • SNCR $10.55
  • TLSA $1.01
  • Resistance Level
  • SNCR $11.55
  • TLSA $1.13
  • Average True Range (ATR)
  • SNCR 0.83
  • TLSA 0.13
  • MACD
  • SNCR -0.10
  • TLSA -0.05
  • Stochastic Oscillator
  • SNCR 41.46
  • TLSA 3.19

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: